Skip to main content

Table 3 Clinicopathological features of patients with PROM1 and CRTC2 mutations

From: Identification and validation of PROM1 and CRTC2 mutations in lung cancer patients

Patient Gender Age (yrs.) Type T N M Stage Differentiation Tumor size (cm) Family history Smoking status Pack years
PROM1
LCa-15 M 58 ADC 1a 0 0 IA Poor 1.2 × 1 × 0.8 No Never  
LC-116 M 70 SCC 4 0 0 IIIA Poor-moderate 13.5 × 12 × 6 Yes Current 182
LC-122 F 59 ADC 2a 1 1b IV Poor 4.3 × 2.3 × 3 No Never  
LC-215 M 68 SCC 2b 1 0 IIB Poor 6.1 × 4.9 × 5 No Current 546
LC-275 F 54 ADC 4 2 1a IV Poor 17 × 11 × 4.1 No Never  
LCTb-17 M 58 ADC 2a 1 0 IIA Moderate 4 × 3.5 × 3.5 No Current 182
LCT-51 M 61 SCC 1a 0 0 IA Poor 2 × 1.5 × 1.4 No Current 364
LCT-181 F 56 ADC 2a 1 0 IIA Moderate-well 4 × 3 × 3 No Never  
CRTC2
LC-207 M 72 ADC 2a 0 0 IB Moderate 2.3 × 3.4 × 2 No Current 365
LC-250 F 65 ADC 2a 1 0 IIA Poor-moderate 4 × 4 × 3.5 No Never  
LCT-81 F 57 ADC 2a 0 0 IB Poor-moderate 3 × 2.5 × 2.5 No Never  
LCT-94 M 69 SCC 1b 0 0 IA Poor 2.5 × 1.5 × 1.0 No Current 500
LCT-111 M 52 SCC 2a 1 0 IIA Poor-moderate 4 × 3.5 × 2.5 No Current 280
LCT-160 M 41 ADC 2a 1 0 IIA Moderate 4 × 3.5 × 4 Yes Never  
LCT-171 F 69 ADC 2a 0 0 IB Poor-moderate 4 × 4 × 3 No Never  
  1. ablood sample of lung cancer; btissue sample of lung cancer and matched normal lung tissue.
  2. ADC, adenocarcinoma; SCC, squamous cell carcinoma.